Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

AM 36 MeSH Supplementary Concept Data 2025


MeSH Supplementary
AM 36
Unique ID
C401121
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C401121
Entry Term(s)
1-(2-(4-chlorophenyl)-2-hydroxy)ethyl-4-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylpiperazine
4-((4-(2-(4-chlorophenyl)-2-hydroxyethyl)-1-piperazinyl)methyl)-2,6-bis(2-methyl-2-propanyl)phenol
AM-36
AM36 compound
CNSB 002
CNSB-002
CNSB002
Pharm Action
Antioxidants
Neuroprotective Agents
Sodium Channel Blockers
Registry Numbers
08OBY024NY
Heading Mapped to
*Piperazines
Frequency
9
Source
Stroke 1999 Dec;30(12):2704-12
Date of Entry
1999/12/09
Revision Date
2017/11/03
AM 36 Preferred
1-(2-(4-chlorophenyl)-2-hydroxy)ethyl-4-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylpiperazine Related
CNSB 002 Narrower
4-((4-(2-(4-chlorophenyl)-2-hydroxyethyl)-1-piperazinyl)methyl)-2,6-bis(2-methyl-2-propanyl)phenol Broader
page delivered in 0.005s